Italy Respiratory Devices Market Size (2024 - 2029)

The Italian respiratory devices market is anticipated to experience growth due to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. The demand for these devices surged during the COVID-19 pandemic, which positively influenced market expansion. As COVID-related restrictions have been lifted, the market is rebounding, driven by the rising incidence of respiratory diseases and new product launches. Despite these growth drivers, the high cost of respiratory devices may pose a challenge to market expansion.

Market Size of Italy Respiratory Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
italy respiratory devices market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 6.80 %
Market Concentration Low

Major Players

Italy Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Italy Respiratory Devices Market Analysis

The Italian respiratory devices market is poised to register a CAGR of 6.8% over the forecast period. The COVID-19 pandemic sparked a rush in the pharmaceutical sector to produce therapeutic and preventive medications. The pandemic favorably impacted the Italian respiratory devices business. According to a study published in the Journal of Respiratory Research in January 2021, COVID- 19 patients had acute respiratory distress syndrome (ARDS), required breathing support, and some had to be hospitalized in the critical care unit (ICU). COVID-19 patients also experienced severe hypoxia with respiratory failure, along with other signs, such as tachypnoea, increased use of accessory muscles, tachycardia, pale and cold periphery, sweating, confusion, agitation, or decreased level of consciousness, and cyanosis. Thus, the demand for respiratory devices significantly increased during the pandemic to provide respiratory support for COVID-19 patients. This positively impacted the growth of the market. Moreover, the market is expected to grow over the forecast period as all COVID-related restrictions have been lifted, and market growth is rebounding by rising respiratory diseases and product launches.

The market for respiratory devices has been growing in Italy due to the increasing prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), TB, Asthma, and sleep apnoea. According to a study published in the National Library of Medicine in March 2022, the CB phenotype was prevalent (48.3%), followed by the E and the A phenotypes (38.8% and 12.8%, respectively). When dyspnoea was the prevailing symptom, the probability of belonging to the COPD-E phenotype was 3.40 times higher. These phenotypes are responsible for the worsening of the COPD . Thus, the increase in the occurrence of the COPD among the Italian population is expected to drive the demand for the respiratory devices over the forecast period.

The country's increasing asthma burden necessitates the use of respiratory devices. According to a study published in the Journal of Asthma in August 2021, the prevalence of asthma in Italy was believed to be around 4%, affecting roughly 2,000,000 persons. Up to 80-90% of patients experience mild-to-moderate asthma each year. Thus, the growing prevalence of respiratory diseases in the country, such as COPD and asthma, are likely to support the growth of the market.

Thus, the aforementioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of devices and instruments might restrain market growth.

Italy Respiratory Devices Industry Segmentation

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. The Italian respiratory devices market is segmented by Type (diagnostic and monitoring devices, therapeutic devices, and disposables). The report offers all values in USD million for the above segments.

By Type
By Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Other Diagnostic and Monitoring Devices
By Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Humidifiers
Nebulizers
Ventilators
Inhalers
Other Therapeutic Devices
By Disposables
Need A Different Region Or Segment?
Customize Now

Italy Respiratory Devices Market Size Summary

The Italian respiratory devices market is experiencing significant growth, driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. The COVID-19 pandemic acted as a catalyst for this growth, as it heightened the demand for respiratory support devices due to the surge in patients requiring mechanical ventilation and other forms of respiratory assistance. The lifting of COVID-related restrictions and the ongoing rise in respiratory diseases are expected to further propel the market's expansion. Despite the high cost of these devices posing a potential challenge, the market is anticipated to continue its upward trajectory, supported by technological advancements and strategic initiatives by key players.

The market landscape is characterized by moderate competition and fragmentation, with several major companies actively engaging in product development, collaborations, and strategic partnerships to enhance their market presence. The ventilator and inhaler segments are particularly poised for growth, driven by the increasing demand for effective treatment options and technology-enabled features. Notable players in the market include Dragerwerk AG, Fisher & Paykel Healthcare Ltd, and GE Healthcare, among others. Strategic activities, such as mergers, acquisitions, and funding for innovative respiratory solutions, are expected to bolster market growth further. The Italian respiratory devices market, supported by a well-structured healthcare system, is set to expand as it addresses the growing burden of respiratory diseases.

Explore More

Italy Respiratory Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Respiratory Disorders

      2. 1.2.2 Technological Advancements and Increasing Applications in Homecare Settings

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Devices

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Type

      1. 2.1.1 By Diagnostic and Monitoring Devices

        1. 2.1.1.1 Spirometers

        2. 2.1.1.2 Sleep Test Devices

        3. 2.1.1.3 Other Diagnostic and Monitoring Devices

      2. 2.1.2 By Therapeutic Devices

        1. 2.1.2.1 Positive Airway Pressure (PAP) Devices

        2. 2.1.2.2 Humidifiers

        3. 2.1.2.3 Nebulizers

        4. 2.1.2.4 Ventilators

        5. 2.1.2.5 Inhalers

        6. 2.1.2.6 Other Therapeutic Devices

      3. 2.1.3 By Disposables

Italy Respiratory Devices Market Size FAQs

The Italy Respiratory Devices Market is projected to register a CAGR of 6.80% during the forecast period (2024-2029)

GE Healthcare, Fisher & Paykel Healthcare Ltd, Medtronic PLC, ICU Medical (Smiths Medical Inc) and Invacare Corporation are the major companies operating in the Italy Respiratory Devices Market.

Italy Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)